ORAL DISPERSIBLE TABLETS: AN OVERVIEW; DEVELOPMENT, TECHNOLOGIES AND EVALUATION
Keywords:
Orodispersible tablets (ODTs), Improved bioavailability and super disintegrates.Abstract
Now-a-days, orodispersible drug delivery systems are extensively used to improve bioavailability and patient compliance. Over the past three decades, orodispersible tablets (ODTs) have gained considerable attention as a preferred alternative to conventional tablets and capsules due to better patient compliance, improved solubility and stability profiles. The purpose of the article is to review potential advancements of ODT technology in drug delivery applications. Various techniques employed to prepare ODTs include direct compression method, freeze drying, spray drying, tablet moulding, sublimation and mass extrusion. ODTs could be preferred choice especially with those drugs sensitive to GI and for patients under category of pediatrics, geriatrics, bedridden, postoperative and who may have difficulty in swallowing the conventional tablets and capsules.ODTs are solid dosage forms containing medicinal substances which disintegrate rapidly, usually in a matter of seconds, when placed on the tongue.ODTs render enhanced acceptability due to its patient compliance as well as improved bioavailability and stability. This article reviews recent trends undertaken to develop ODTs, new ODTs technologies, suitability of drug candidate and characterization of ODTs.
Downloads
References
Valleri M, Mura P, Maestrelli F, Cirri M, Ballerini R, Development and evaluation of glyburide fast dissolving tablets using solid dispersion technique. Drug Dev Ind Pharm, 30 (5): 525-534, (2004).
Sastry SV, Nyshdham JR, Fix JA. Recent technological advances in oral drug delivery: A review. Pharmaceutical Science and Technology Today. 2000; 3:138-45.
Seager H. Drug-delivery products and the Zydis fast- dissolving dosage form. Journal of Pharmacy and Pharmacology. 1998; 50(4):375-82.
Fu Y, Yang S, Jeong SH, Kimura S, Park K (2004). Orally fast disintegrating tablets: Developments, technologies, taste masking and clinical studies. Crit Rev Ther Drug Carrier Syst21: 433–76.
Tejvir Kaur at all and co. a Review article an Month dissolving tablets published in international journal of current pharmaceutical research in vol-3; issue-1-2011.
Brown D (2001). Orally disintegrating tablets: Taste over speed. Drug Deliv Technol 3: 58-61.
Mrs. Rajeshree Panigrahi at all and co a review article on fact dissolving tablets published in webl medcentral.com; article ID-Wmc00809; 29-sep- 2010.
Patel.H A, Patel J.K, Patel K.N and Patel R.R. Studies on formulation and in vitro evaluation of fast dissolving tablets of domperidone. Indian J Pharm Sci, 2010; 2 (1):470-476.
Chackol A.j, Josel S, Babul N, Michellel M, Design and Development of Orodispersible tablets of Promethazine Theoclate Using Coprocessed Superdisintegrants and Subliming Materials, International Journal of Innovative Pharmaceutical Research, 1(2), 2010, 53-56.
Dobetti L, Fast disintegrating tablets, US Patent 2003, 6:596, 311.
Behnke K, Sogaard J, Martin S, Bauml J, Ravindran AV, Agren H; et al. Mirtazapine orally disintegrating tablet versus sertraline, A prospective onset of action study, J Clin Psychopharmacology, 23,2 003, 358-64.
Kumar V.Dinesh, Sharma Ira, Sharma Vipin, A comprehensive review on fast dissolving tablet technology, Journal of Applied Pharmaceutical Science 01 (05), 2011,50-58.
Patidar A, Mishra P, Main P, Harsoliya MS, Agarwal S. A Review On- Recent Advancement in the Development of Rapid Disintegrating Tablet. International Journal of Life science & Pharma Research. 2011; 1(1): 7-16.
Saroha K, Mathur P, Verma S, Syan N, Kumar A. Mouth Dissolving Tablets: An Overview on Future Compaction in Oral Formulation Technologies. Der Pharmacia Sinica. 2010; 1(1):179-187.
Saxena V, Khinchi MP, Gupta MK, Agarwal D, Sharma
N. Orally Disintegrating Tablets: Friendly Dosage Form. International Journal of Research in Ayurveda & Pharmacy. 2010; 1: 399-407.
Virely P, Yarwood R. Zydis – a novel, Fast Dissolving Dosage Form. Manuf Chem. 1990; 61: 36-37.
Kumari S, Visht S, Sharma PK, Yadav RK. Fast Dissolving Drug Delivery System: Review Article. Journal of Pharmacy Research. 2010; 3(6): 1444- 1449.
Bhowmik D, Chranjib B, Pankaj K, Chandira RM. Fast Dissolving Tablet: An Overview. Journal of Chemical and Pharmaceutical Research. 2009; 1(1):163-177.
Gregory, GKE and Ho, D, Pharmaceutical dosage form package, US patent, 1981, 4, 305,502.
Blank, RG and Mainitho, Y, Fast dissolving dosage forms, US patent, 1990, 4,946,684.
Vanscoik, KG, Solid pharmaceutical dosage in tablet triturate form and method of producing same, US patent, 1992, 5,082,667.
Pebley, WS, Rapidly disintegrating tablet, US patent, 1994, 5,298,261.
Koizumi, K, Watanabe, Y, Morita, K, Utoguchi, N and Matsumoto, M, New method of preparing high porosity rapidly saliva soluble compressed tablets using mannitol with camphor, a subliming material,Int. J. Pharm., 152, 1997, 127-131.
Makino, T, Fast dissolving tablet and its production, US patent, 1998, 5,720,974.
Allen, LV and Wang, BM, Process for making a particulate support matrix for making rapidly dissolving tablet, US patent, 1996, 5,587,180.
Allen, L. V., Method for producing a rapidly dissolving dosage form, US patent, 2000, 6,066,337.
Ishikawa, T, Mukai, B, Shiraishi, S, Naoki, U, Makiko, F, Matsumoto, M and Watanabe, Y, Preparation and evaluation of tablets rapidly disintegrating in saliva containing bitter taste-masked granules by the compression method, Chem. Pharm. Bull., 47(10), 1999, 1451-1454.
Bhaskaran, S and Narmada, GV, Indian Pharmacist, 1(2), 2002, 9-12.
Dor JM, Fix JA, Johnson MI. A new in vitro method to measure the disintegration time of a fast disintegration tablet. ProcIntSymp Control RelBioact Mater. 1999; 26: 939–940.
Makino T, Yamada M, Kikuta JI. Fast-dissolving tablet and its production. US Patent 5,720,974. 1998 Feb 24.
Elan Corporation, plc. Orally Disintegrating Tablets (ODT)NanomeltTM.http://www.elan.com/EDT/nanocrys tal%5Ftechnology/orally_disintegrating_tablet.asp
Bess W S, Kulkarni N, Ambike SH, Ramsay MP. Fast dissolving orally consumable solid Film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3to 3:1. US Patent 7067116. 2006 Jun 27.
Amin, A.F., Shah, T.J., Bhadani, M.N., Patel, M.M., Emerging trends in orally disintegrating tablets, www.pharminfo.net, 2005.
Pahwa R, Piplani M, Sharma PC, Kaushik D, Nanda S, Orally disintegrating tablets Friendly to pediatrics and geriatrics, Arch ApplSci Res. ,2010, 2(2), 35-48.
Knitsch KW, Hagen A, Munz E and Determann H. Production of porous tablets. US Patent 1979; No. 4134943.
Kuno Y., Kojima M., Ando S. and Nakagami H. Evaluation of rapidly disintegrating tablets manufactured by phase transition of sugar alcohols. J. Control Release. 2005; 105: 16-22.
Panigrahi D, Baghel S and Mishra B. Mouth dissolving tablets: An overview of preparations techniques, evaluation and patented technologies. J Pharm Res 2005; 4(3):35‐38.
Patel S.S., Pate M.S., Patel N.M., (2009).,Flow ability testing of directly compressible excipients according to british pharmacopoeia; Journal of Pharmaceutical Research Vol. 8.66 -69
Masaki, K., Intrabuccaly disintegrating preparation and production thereof, US PatentNo.5, 466,464, 1995
Sahu et al., Novel Science International Journal of Pharmaceutical Science (2012), 1(3):204-211.
Zhao, N. and L.L.Augsburger, 2005. The influence of swelling capacity of superdisintegrants in different pH media on the dissolution of hydrochlorothiazide from directly compressed tablets. AAPS Pharm. Sci.Tech., 6(1): E120-E126.
Kaur T., Gill B., Kumar S., Gupta G.D., Mouth dissolving tablets: A novel approach to drug delivery, International journal of current pharmaceutical research 2011; 3:1:1-7.
Krishnakanth B, Pankaj N, Margret CR, J Chemical and Pharmaceutical Res, 2009, 1, 163-177.
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN: 0974-4304 Vol.1, No.4, pp 1079- 1091, Oct-Dec 2009.
Pahwa R. and Gupta N. Superdisintegrants in the Development of Orally Disintegrating Tablets: A Review. Int. J. Pharm. Sci. Res. 2011; 2: 2767-2780.
Jaccard TT, Leyder J, Une nouvelle forme galenique le lyoc, Ann Pharm Fr, 43, 1985, 23-31.
Reddy LH, Ghosh BR. Fast dissolving drug delivery systems a review of the literature. Ind J Pharm Sci, 64(4), 2002, 331-336.
Aurora J, Pathak V. Oral disintegrating technologies, Oral disintegrating dosage forms, an overview. Drug Deliv Technol, 2005, 5(3), 50-54.
Hamilton EL, Luts EM. Advanced Orally disintegrating tablets bring significant benefits to patients and product life cycle, Drug Deliv Technol, 5(1), 2005, 34- 37.
Ghosh TK, Chatterjee DJ, Pfister WR, Quick dissolving oral dosage forms Scientific and regulatory considerations from a clinical pharmacology and biopharmaceutical Perspective. In Ghosh TK and Pfister WR (Eds), Drug Delivery to the Oral Cavity, Molecules to Market, NY, USA: CRC Press, 2005, 337-356.
Habib W, Khankari R, Hontz J, Fast-dissolving drug delivery system, Crit. Rev. Ther. Drug Carrier Syst, 17, 2000, 61–72.
Sugihara M, Hidaka M, Saitou A. Discriminatory features of dosage form and package, Jpn J Hosp Pharm, 12, 1986,322-328.
Seager H, Drug-delivery products and the Zydis Fast dissolving dosage form, J. Pharm. Pharmacol, 50, 1998, 375–382.
Lies MC, Atherton AD, Copping NM, Freeze-dried dosage forms and methods for preparing same, US Patent5, 188,825, 1993.
Sehgal P et al. Fast dissolving tablets: a new venture in drug delivery. American Journal of PharmTech Research 2012; 2(4):252-279.
Mohanachandran PS, Sindhumol PG, Kiran TS. Superdisintegrants: An overview, International Journal of Pharmaceutical Sciences Review and Research 2011; 6:105-109.
Sharma S. New Generation of Tablet: Fast Dissolving Tablet. Latest Reviews. Pharmainfo.Net 2008; 6(1).
Kumaresan C. Orally Disintegrating Tablet-Mouth dissolving, Sweet Taste and Target Release Profile. Pharmaceutical review 2008; 6.
Johnson JR, Wang LH, Gordon MS, Chowhan ZT. Effect of formulation solubility andHygroscopicity on disintegrating efficiency in tablets prepared by wet granulation. Journal of Pharmaceutical Sciences 1991; 80:469–71.
Pandya HB, Callan TP. U.S. Patent 5, 837, 286.1998.
Patel S Taher, Sengupta Mukul. Fast Dissolving Tablet Technology – A Review. World Journal of Pharmacy and Pharmaceutical Sciences 2013; 2 (2): 485-508.
Kumari S, Visht S, Sharma PK, Yadav RK. Fast dissolving Drug delivery system: Review Article; Journal of Pharmacy Research 2010; 3(6):1444-1449.
Pfista WR, Gosh TK, Orally disintegrating tablets, Pharma Tech, Oct 2, 2006, (PATENT)
Bangale G.S, Yadav G.J, Shinde G.V, Rathinaraj B.Stephen, Review on New generation of Orodispersible Tablets, Recent Advances and Future Prospects, InternationalJournal of Pharmacy and Pharmaceutical Science Research,1(2), 2011, 52-62,
Hirani Jaysukh J, A Review on Orally Disintegrating Tablets, Tropical journal of Pharmaceutical research, 8(2), 2009, 161-172.
Wilson C.G., Washington N., Peach J., Murray G.R., Kennerley J., The behaviour of a fast-dissolving dosage form (Expidet) followed by gscintigraphy, International Journal of Pharmaceutics 1987; 40: 119–123.
Srivastava S.B., Joshi R.B., Rana A.C., Singla V., Mouth dissolving tablets: A future compaction, IRJP 2012; 3(8): 107.
Bi Y., Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity, Chem Pharm Bull, 1996; 44: 2121-2127.
Subramanian S, Sankar V, Manakadan AA, Ismailand S, Andhuvan G. Formulation and Evaluation of Cetirizine dihydrochloride Orodispersible Tablet. Pak.J.Pharm. Sci. 2010; 239 (2): 232-235.
Kuno Y, Kojima M, Ando S, Nakagami H. Evaluation of Rapidly Disintegrating Tablets Manufactured by Phase Trasition of Sugar Alcohol. Journal of Controlled Release. 2005; 105: 16-22.
Mutalik S, Shetty RS. Formulation and Evaluation of Directly Compressible Tablets of Panchgani lavana. Int. J. Pharm. 2004; 278: 423-433.
Bi Y, Evaluation of rapidly disintegrating tablets prepared by direct compression method, Drug Dev Ind Pharm 1999; 25:5: 571-581.
Jeong SH, Takaishi Y, Park K. Material properties for making fast dissolving tablets by a compression method. Journal of Materials Chemistry 2008; 18: 3527–3535.
Kumar S, Gupta SK, Sharma PK. A Review on Recent Trends in Oral Drug Delivery-FastDissolving Formulation Technology. Advances in Biological Res 2012; 6 (1): 06-13.
Chaudhari PD, Chaudhari SP, Kolhe SR, Dave KV, More DM. Formulation and evaluation of fast dissolving tablets of famotidine. Indian Drugs 2005; 42: 641- 649.
Nandgude TD, Saifee M, Bhise KS. Formulation and evaluation of fast disintegrating tablets of diphenhydramine tannate. Asian Journal of Pharmaceutical Science 2006; 1(1):41-45.
Wilson C.G., Washington N., Peach J., Murray G.R., Kennerley J., The behaviour of a fast-dissolving dosage form (Expidet) followed by gscintigraphy, Int J Pharm 1987; 40: 119–123.
Wilson CG, Washington N, Norman S, Greaves JL, Peach JM, Pugh K. A gamma scintigraphic study to compare oesophageal clearance of “Expidet” formulation, tablets and capsules in supine volunteers. Int. J.Pharm. 1988; 46 (3): 241-246.
Washington N, Wilson CG, Greaves JL, Norman S, Peach JM, Pugh K. A gamma scintigraphic study of gastric coating by Expidet, tablets and liquid formulation. Int. J. Pharm. 1989; 57(1): 17-22.
United State Pharmacopoeia USP25 NF20. The official compendia of standard of Rockville, MD: United State Pharmacopoeia Convention Inc.2002.
Divate S, Kunchu K, Sockan GN. Fast Disintegrating tablet an Emerging Trend. International Journal of Pharmaceutical Science Review and Research. 2011; 6 (2): 18-22.
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
.